Description
Scriptaid is an inhibitor of histone deacetylases that exhibits anticancer activity. In non-small cell lung cancer (NSCLC) cells, scriptaid downregulates expression of Chk1. In glioma cells, scriptaid increases activation of JNK and p38 MAPK, expression of p21 and p27, and activity of Ras; it also decreases activity of telomerase, inducing apoptosis and decreasing proliferation. In somatic cell nuclear transfer, scriptaid improves the quality of cloned mouse embryos.